Liabilities of Oncotelic Therapeutics, Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
Oncotelic Therapeutics, Inc. quarterly Liabilities in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Oncotelic Therapeutics, Inc. Liabilities for the quarter ending 30 Sep 2025 was $20,079,663, a 7.7% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Change (%)

Oncotelic Therapeutics, Inc. Quarterly Liabilities (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $20,079,663 +$1,429,390 +7.7% 30 Sep 2025 10-Q 17 Nov 2025 2025 Q3
Q2 2025 $19,286,912 +$855,362 +4.6% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $19,484,762 +$759,742 +4.1% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $19,199,914 +$796,499 +4.3% 31 Dec 2024 10-Q 17 Nov 2025 2025 Q3
Q3 2024 $18,650,273 30 Sep 2024 10-Q 19 Nov 2024 2024 Q3
Q2 2024 $18,431,550 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $18,725,020 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $18,403,415 +$1,480,008 +8.7% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q4 2022 $16,923,407 31 Dec 2022 10-K 12 Apr 2024 2023 FY
Q4 2011 $2,259,000 -$8,563,000 -79% 31 Dec 2011 10-K 28 Mar 2012 2011 FY
Q3 2011 $2,978,000 30 Sep 2011 10-Q 10 Nov 2011 2011 Q3
Q2 2011 $2,238,000 30 Jun 2011 10-Q 12 Aug 2011 2011 Q2
Q4 2010 $10,822,000 31 Dec 2010 10-K 28 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.